SEC filing record
Primary Source · SEC.gov

NLC Florida Healthcare Sciences DST

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalFirst saleForm D/A · 2026-10-085 events: 1 first sale, 1 sold increased, 1 investors increasedLast filing 2026-10-08

Raised

$46M

Investors

24

Min Invest

$150,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

NLC Florida Healthcare Sciences DST is a Delaware entity organized in 2026 that first filed a Form D on August 25, 2026 and most recently amended it on October 8, 2026 in the Other Real Estate industry group. The offering claims Rule 506(b). NLC Florida Healthcare Sciences DST reported $45,907,278 sold from 24 investors of a $97,038,429 total offering as of the Form D filed October 8, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $150,000. The Form D names Edward Eric Fernandez (CRD 002956661), associated with Capulent LLC; Robert Dale Mutch (CRD 005966517), associated with Emerson Equity LLC; Bruce Ira Greenberg (CRD 002638679), associated with Kingswood Capital Partners, LLC; Simon Louber Brower (CRD 004496781), associated with Realized Financial, Inc. and 6 others as recipients of sales compensation. Sales commissions are reported as $410,634 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is C/O Net Lease Capital Advisors LLC, 10 Tara Boulevard, Suite 501, Nashua, NH 03062.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002151117
Entity NameNLC Florida Healthcare Sciences DST
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeOther
Jurisdiction of OrganizationDelaware
Year Organized2026
Issuer AddressC/O Net Lease Capital Advisors LLC, 10 Tara Boulevard, Suite 501, Nashua, NH 03062
Phone(603) 966-0204
Industry / Fund TypeOther Real Estate
Securities Type—
First Sale DateSeptember 1, 2026
Filing DateOctober 8, 2026
Accession Number0000932440-26-000036
Total Offering Amount$97,038,429
Total Amount Sold$45,907,278
Amount Remaining$51,131,151
Total Investors24
Non-Accredited InvestorsNone
Minimum Investment$150,000
Offering DurationIntended to last more than one year
Sales Commissions$410,634 (to Edward Eric Fernandez and 9 others)
Finders' Fees$0
Proceeds to Related Persons$0
Revenue RangeNot Applicable
State (Issuer Address)NH
Amendment Count2 filings on record
Signed ByBruce S. MacDonald, Manager

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest Oct 8, 2026

Critical / warning

0 / 0

3 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event First sale · Oct 8, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 5 filing events with values and deltas, latest 2026-10-08, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Douglas F. Blough

Executive Officer · Nashua, NH

Bruce S. MacDonald

Executive Officer · Nashua, NH

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Edward Eric FernandezCRD 002956661 on BrokerCheck

Associated broker-dealer: Capulent LLC (CRD 000155155) · Irvine, CA

Robert Dale MutchCRD 005966517 on BrokerCheck

Associated broker-dealer: Emerson Equity LLC (CRD 000130032) · Greenwood Village, CO

Bruce Ira GreenbergCRD 002638679 on BrokerCheck

Associated broker-dealer: Kingswood Capital Partners, LLC (CRD 000288898) · White Plains, NY

Simon Louber BrowerCRD 004496781 on BrokerCheck

Associated broker-dealer: Realized Financial, Inc. (CRD 000022333) · Austin, TX

Scott David OffermanCRD 004619093 on BrokerCheck

Associated broker-dealer: 1031 Securities Inc. (CRD 000326590) · Franklin, TN

Adam Roy Van DykeCRD 003008054 on BrokerCheck

Associated broker-dealer: Emerson Equity LLC (CRD 000130032) · San Mateo, CA

Daniel James MercerCRD 006698392 on BrokerCheck

Associated broker-dealer: Emerson Equity LLC (CRD 000130032) · San Mateo, CA

Bradford Lee WattCRD 002565438 on BrokerCheck

Associated broker-dealer: Saxony Securities, Inc. (CRD 000115547) · St. Louis, MO

Nicholas Robert SnyderCRD 007138151 on BrokerCheck

Associated broker-dealer: FNEX Capital, LLC (CRD 000166316) · Indianapolis, IN

Bryan Robert CoglianoCRD 004367535 on BrokerCheck

Associated broker-dealer: Arkadios Capital (CRD 000282710) · Berwyn, PA

Questions About NLC Florida Healthcare Sciences DST

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is NLC Florida Healthcare Sciences DST?

NLC Florida Healthcare Sciences DST is a Delaware entity organized in 2026 that filed a Form D with the SEC on October 8, 2026 in the Other Real Estate industry group. The filing claims Rule 506(b).

Is NLC Florida Healthcare Sciences DST legit?

AltStreet does not rate legitimacy; it reports the public record. NLC Florida Healthcare Sciences DST filed a Form D with the SEC on October 8, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $45,907,278 sold to 24 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is NLC Florida Healthcare Sciences DST registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that NLC Florida Healthcare Sciences DST claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has NLC Florida Healthcare Sciences DST raised?

NLC Florida Healthcare Sciences DST reported $45,907,278 sold from 24 investors of a $97,038,429 total offering as of the Form D filed October 8, 2026.

Who can invest in NLC Florida Healthcare Sciences DST?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $150,000.

What is the minimum investment in NLC Florida Healthcare Sciences DST?

The Form D lists $150,000 as the minimum investment accepted from any outside investor as of October 8, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling NLC Florida Healthcare Sciences DST and how are they paid?

The Form D names Edward Eric Fernandez (CRD 002956661), associated with Capulent LLC; Robert Dale Mutch (CRD 005966517), associated with Emerson Equity LLC; Bruce Ira Greenberg (CRD 002638679), associated with Kingswood Capital Partners, LLC; Simon Louber Brower (CRD 004496781), associated with Realized Financial, Inc. and 6 others as recipients of sales compensation. Sales commissions are reported as $410,634 and finders' fees as $0. Form D allows these to be estimates.

Who is behind NLC Florida Healthcare Sciences DST?

The Form D lists 2 related persons: Douglas F. Blough, executive officer; Bruce S. MacDonald, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is NLC Florida Healthcare Sciences DST located?

The issuer's address on its SEC filings is C/O Net Lease Capital Advisors LLC, 10 Tara Boulevard, Suite 501, Nashua, NH 03062. Its phone number of record is 603-966-0204. It is organized under the laws of Delaware.

How long is the NLC Florida Healthcare Sciences DST offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

What is NLC Florida Healthcare Sciences DST's revenue?

The Form D reports a revenue range of Not Applicable.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.